Has Francis Grillo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $333 in general payments to Francis Grillo, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Francis Grillo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Francis Grillo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Francis Grillo, MD

Nephrology · Gettysburg, PANPI 1649376088

Payments from drug & device makers

$333in general payments, 2019–2025

Across 29 payments — averaging $11.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Dexcom, Inc.$104
Travere Therapeutics, Inc.$72
Amgen$45
AstraZeneca$36
Bayer$33
Vifor Pharma, Inc.$24
plus $17 from 1 others

What the payments were for

Food & beverage$27482%
Education$5918%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Dexcom, Inc.	5	$104
Travere Therapeutics, Inc.	16	$72
Amgen	2	$45
AstraZeneca	2	$36
Bayer	2	$33
Vifor Pharma, Inc.	1	$24
Lilly USA, LLC	1	$17

How this compares

$333 in reported general payments places this provider in the 35th percentile of 586 nephrology providers in Pennsylvania.

See all nephrology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$4,442

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	15	$8,592
EliquisApixaban	16	$7,221
TradjentaLinagliptin	11	$5,136
ProsolParenteral Amino Acid 20% No.1	19	$4,503
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	30	$896
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	22	$806
Gabapentin	32	$481
Atorvastatin Calcium	58	$469
Amlodipine Besylate	63	$290
Famotidine	19	$235
Hydralazine Hcl	25	$228
Zolpidem Tartrate	16	$207
Carvedilol	29	$207
Omeprazole	21	$160
Levothyroxine Sodium	32	$151

Paid to pharmacies, not to this prescriber.

Other nephrology in Gettysburg

Katalin SusztakPhiladelphia$4.8M
Debbie Cohen SteinPhiladelphia$2.8M
Nelson KopytAllentown$2.1M
Iris LeePhiladelphia$1.9M
Abdallahsassine GearaPhiladelphia$1.2M
Alexander ChangDanville$1000K
Gaia MuallemPhiladelphia$942K
Chike OkechukwuUpland$875K
Christopher GislerPittsburgh$757K
Umar FarooqHershey$723K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →